The DOI matches its Crossref record; 717 of the 717 references it cites were found in a registry or an index.
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
Abstract
The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections. This guidance document focuses on infections caused by extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), AmpC β-lactamase-producing Enterobacterales (AmpC-E), carbapenem-resistant Enterobacterales (CRE), Pseudomonas aeruginosa with difficult-to-treat resistance (DTR P. aeruginosa), carbapenem-resistant Acinetobacter baumannii (CRAB), and Stenotrophomonas maltophilia. This updated document replaces previous versions of the guidance document. A panel of 6 infectious diseases specialists with expertise in managing antimicrobial-resistant infections formulated questions about the treatment of infections caused by ESBL-E, AmpC-E, CRE, DTR P. aeruginosa, CRAB, and S. maltophilia. Because of differences in the epidemiology of AMR and availability of specific anti-infectives internationally, this document focuses on the treatment of AMR infections in the United States. Preferred and alternative suggested treatment approaches are provided with accompanying rationales, assuming the causative organism has been identified and antibiotic susceptibility results are known. Approaches to empiric treatment, transitioning to oral therapy, duration of therapy, and other management considerations are discussed briefly. Suggested approaches apply for both adult and pediatric populations, although suggested antibiotic dosages are provided only for adults. The field of AMR is highly dynamic. Consultation with an infectious diseases specialist is recommended for the treatment of AMR infections. This document is current as of December 31, 2023 and will be updated periodically. The most current version of this document, including date of publication, is available at www.idsociety.org/practice-guideline/amr-guidance/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 717
Lahiri, S. D., Walkup, G. K., Whiteaker, J. D., Palmer, T., McCormack, K., Tanudra, M. A., Nash, T. J., Thresher, J., Johnstone, M. R., Hajec, L., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv004 · Cited by 129
Matsumura, Y., Yamamoto, M., Nagao, M., Komori, T., Fujita, N., Hayashi, A., Shimizu, T., Watanabe, H., Doi, S., Tanaka, M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00701-15 · Cited by 129
Sader, H. S., Castanheira, M., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02429-13 · Cited by 129
Popejoy, M. W., Paterson, D. L., Cloutier, D. J., Huntington, J. A., Miller, B. W., Bliss, C. A., Steenbergen, J. N., Hershberger, E., Umeh, O., & Kaye, K. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw374 · Cited by 129
Jung, S. Y., Lee, S. H., Lee, S., Yang, S., Noh, H., Chung, E. K., & Lee, J. I. (2017) · Critical Care · doi:10.1186/s13054-017-1916-6 · Cited by 129
Zha, L., Pan, L., Guo, J., French, N., Villanueva, E., & Tefsen, B. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01235-y · Cited by 129
Marchaim, D., Chopra, T., Bhargava, A., Bogan, C., Dhar, S., Hayakawa, K., Pogue, J. M., Bheemreddy, S., Blunden, C. E., Shango, M. M., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/666642 · Cited by 128
Self-citationWang, Q., Jin, L., Sun, S., Yin, Y., Wang, R., Chen, F., Wang, X., Zhang, Y., Hou, J., Zhang, Y., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02670-21 · Cited by 128
Gallagher, J. C., Satlin, M. J., Elabor, A., Saraiya, N., McCreary, E. K., Molnar, E., El‐Beyrouty, C., Jones, B. M., Dixit, D., Heil, E. L., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy280 · Cited by 127
Self-citationBella, S. D., Giacobbe, D. R., Maraolo, A. E., Viaggi, V., Luzzati, R., Bassetti, M., Luzzaro, F., & Principe, L. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.04.001 · Cited by 127
Barnhill, A. E., Brewer, M. T., & Carlson, S. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00678-12 · Cited by 126
Karlowsky, J. A., Biedenbach, D. J., Kazmierczak, K. M., Stone, G. G., & Sahm, D. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02286-15 · Cited by 126
Dickstein, Y., Lellouche, J., Dalak, M. A. B., Schwartz, D. A., Nutman, A., Daitch, V., Yahav, D., Leibovici, L., Skiada, A., Antoniadou, A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy988 · Cited by 125
Grillon, A., Schramm, F., Kleinberg, M., & Jehl, F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156690 · Cited by 124
Livermore, D. M., Day, M. J., Cleary, P. R., Hopkins, K. L., Toleman, M. A., Wareham, D. W., Wiuff, C., Doumith, M., & Woodford, N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky453 · Cited by 124
Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline
Fluit, A. C., Florijn, A., Verhoef, J., & Milatović, D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1636-1638.2005 · Cited by 122
Burkhardt, O., Kumar, V., Katterwe, D., Majcher-Peszynska, J., Drewelow, B., Derendorf, H., & Welte, T. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl485 · Cited by 122
Falagas, M. E., Skalidis, T., Vardakas, K. Z., Legakis, N. J., & on behalf of the Hellenic Cefiderocol Study Group (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx049 · Cited by 122
Wang, M., Ge, L., Chen, L., Komarow, L., Hanson, B., Reyes, J., Cober, E., Alenazi, T. H., Zong, Z., Xie, Q., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad556 · Cited by 122
Self-citationSimner, P. J., Mostafa, H. H., Bergman, Y., Ante, M., Tekle, T., Adebayo, A., Beisken, S., Dzintars, K., & Tamma, P. D. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab888 · Cited by 121
Self-citationTimsit, J., Paul, M., Shields, R. K., ECHOLS, R. M., Baba, T., Yamano, Y., & Portsmouth, S. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac078 · Cited by 121
Sader, H. S., Castanheira, M., Shortridge, D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01045-17 · Cited by 120
Kohlmann, R., Bähr, T., & Gatermann, S. G. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky084 · Cited by 120
Papp‐Wallace, K. M., Bethel, C. R., Caillon, J., Barnes, M. D., Potel, G., Bajaksouzian, S., Rutter, J. D., Reghal, A., Shapiro, S., Taracila, M. A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00105-19 · Cited by 120
Self-citationClass C β-Lactamases: Molecular Characteristics
Philippon, A., Arlet, G., Labia, R., & Iorga, B. I. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00150-21 · Cited by 120
Karlowsky, J. A., Hackel, M., McLeod, S. M., & Miller, A. A. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00781-22 · Cited by 120
Freire, M. P., Garcia, D. D. O., Garcia, C. P., Bueno, M. F. C., Camargo, C. H., Magri, A. S. G. K., Francisco, G. R., da Silva, R. R., Vieira, M. F., Ibrahim, K. Y., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.010 · Cited by 119
Nakamura, R., Ito-Horiyama, T., Takemura, M., Toba, S., Matsumoto, S., Ikehara, T., Tsuji, M., Sato, T., & Yamano, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02031-18 · Cited by 119
Accurate Identification of Clinically Important Acinetobacter Spp.: An Update
Vijayakumar, S., Biswas, I., & Veeraraghavan, B. (2019) · Future Science OA · doi:10.2144/fsoa-2018-0127 · Cited by 119
Ko, J., Kang, C., Cornejo‐Juárez, P., Yeh, K., Wang, C.-H., Cho, S. Y., Gözel, M. G., Kim, S., Hsueh, P., Sekiya, N., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.008 · Cited by 118
Walkty, A. J., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 116
Goodlet, K. J., Benhalima, F. Z., & Nailor, M. D. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02165-18 · Cited by 116
Chopra, T., Marchaim, D., Veltman, J., Johnson, P., Zhao, J. J., Tansek, R., Hatahet, D., Chaudhry, K., Pogue, J. M., Hiro, R., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05419-11 · Cited by 115
Seo, Y. B., Lee, J., Kim, Y. K., Lee, S. S., Lee, J.-A., Kim, H. Y., Uh, Y., Kim, H.-S., & Song, W. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2502-x · Cited by 115
Lee, C.-H., Su, L.-H., Tang, Y., & Liu, J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl381 · Cited by 114
LUCASTI, C. J., Hershberger, E., Miller, B. W., Yankelev, S., Steenbergen, J. N., Friedland, I. R., & Solomkin, J. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00049-14 · Cited by 114
Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?
Gardiner, B. J., Mahony, A. A., Ellis, A. G., Lawrentschuk, N., Bolton, D. M., Zeglinski, P. T., Frauman, A. G., & Grayson, M. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit704 · Cited by 112
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections
Ni, W., Han, Y., Liu, J., Wei, C., Zhao, J., Cui, J., Wang, R., & Liu, Y.-N. (2016) · Medicine · doi:10.1097/md.0000000000003126 · Cited by 112
Jacobs, M. R., Abdelhamed, A. M., Good, C. E., Rhoads, D. D., Hujer, K. M., Hujer, A. M., Domitrovic, T., Rudin, S. D., Richter, S. S., van Duin, D., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01801-18 · Cited by 112
Self-citationCeftazidime/avibactam resistance associated with L169P mutation in the omega loop of KPC-2
Hemarajata, P., & Humphries, R. M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz026 · Cited by 112
Farrell, D. J., Sader, H. S., & Jones, R. N. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01774-09 · Cited by 111
Kuo, L.-C., Lai, C., Liao, C., Hsu, C.-K., Chang, Y.-L., Chang, C.-Y., & Hsueh, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01601.x · Cited by 110
Molecular basis of beta-lactamase induction in bacteria
Bennett, P. M., & Chopra, I. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.153 · Cited by 109
Synergistic combinations of polymyxins
Lenhard, J. R., Nation, R. L., & Tsuji, B. T. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.014 · Cited by 108
Seifert, H., Stefanik, D., Sutcliffe, J. A., & Higgins, P. G. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.022 · Cited by 108
Hsueh, S.-C., Lee, Y., Huang, Y., Liao, C., Tsuji, M., & Hsueh, P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky425 · Cited by 108
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases
Maselli, D. J., Keyt, H., & Restrepo, M. I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051062 · Cited by 107
Zhang, Y., Kashikar, A., Brown, C. A., Denys, G. A., & Bush, K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00389-17 · Cited by 107
Papp‐Wallace, K. M., Barnes, M. D., Alsop, J., Taracila, M. A., Bethel, C. R., Becka, S. A., van Duin, D., Kreiswirth, B. N., Kaye, K. S., & Bonomo, R. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00174-18 · Cited by 107
Self-citationTigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
Poulakou, G., Kontopidou, F. V., Paramythiotou, E., Kompoti, M., Katsiari, M., Mainas, E., Nicolaou, C., Yphantis, D., Antoniadou, A., Trikka‐Graphakos, E., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.02.009 · Cited by 106
Shields, R. K., McCreary, E. K., Marini, R. V., Kline, E. G., Jones, C. E., Hao, B., Chen, L., Kreiswirth, B. N., Doi, Y., Clancy, C. J., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1131 · Cited by 106
Hancock, R. E. W., & Bellido, F. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.suppl_a.1 · Cited by 105
Cho, S. Y., Kang, C., Kim, J., Ha, Y. E., Chung, D. R., Lee, N. Y., Peck, K. R., & Song, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01682-13 · Cited by 105
Biagi, M. J., Wu, T., Lee, M., Patel, S., Butler, D. A., & Wenzler, E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01426-19 · Cited by 105
Karlowsky, J. A., Hackel, M. A., Takemura, M., Yamano, Y., Echols, R., & Sahm, D. F. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01990-21 · Cited by 104
Iovleva, A., Mustapha, M. M., Griffith, M. P., Komarow, L., Luterbach, C., Evans, D. R., Cober, E., Richter, S. S., Rydell, K., Arias, C. A., et al. (2022) · mBio · doi:10.1128/mbio.02759-21 · Cited by 104
Self-citationVanScoy, B. D., Mendes, R. E., Nicasio, A. M., Castanheira, M., Bulik, C. C., Okusanya, Ó. O., Bhavnani, S. M., Forrest, A., Jones, R. N., Friedrich, L. V., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02513-12 · Cited by 103
Petrosillo, N., Giannella, M., Antonelli, M. M., Antonini, M., Baršić, B., Belancic, L., İnkaya, A. Ç., PASCALE, G. D., Grilli, E., Tumbarello, M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-13 · Cited by 103
Kalın, G., Alp, E., Demiraslan, H., Doğanay, M., Coskun, R., & Gündoğan, K. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0430-7 · Cited by 101
Activity of Ertapenem (MK-0826) versus Enterobacteriaceae with Potent β-Lactamases
Livermore, D. M., Oakton, K. J., Carter, M. W., & Warner, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2831-2837.2001 · Cited by 101
Compain, F., & Arthur, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00451-17 · Cited by 101
Matsumoto, S., Singley, C. M., Hoover, J. L., Nakamura, R., ECHOLS, R. M., Rittenhouse, S. F., Tsuji, M., & Yamano, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-17 · Cited by 101
Monogue, M. L., Tsuji, M., Yamano, Y., ECHOLS, R. M., & Nicolau, D. P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01022-17 · Cited by 101
Morrissey, I., Olesky, M., Hawser, S., Lob, S. H., Karlowsky, J. A., Corey, G. R., Bassetti, M., & Fyfe, C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01699-19 · Cited by 101
Karaiskos, I., Daikos, G. L., Gkoufa, A., Adamis, G., Stefos, A., Symbardi, S., Chrysos, G., Filiou, E., Basoulis, D., Mouloudi, E. K., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa503 · Cited by 101
López-Cortés, L. F., Cisneros, J. M., Fernández-Cuenca, F., Bou, G., Tomás, M., Garnacho‐Montero, J., Pascual, Á., Martı́nez-Martı́nez, L., Vilà, J., Pachón, J., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku233 · Cited by 100
Heil, E. L., Bork, J. T., Abbo, L. M., Barlam, T. F., Cosgrove, S. E., Davis, A. E., Ha, D. R., Jenkins, T. C., Kaye, K. S., Lewis, J. S., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab434 · Cited by 100
Self-citationPolymyxin B and colistimethate are comparable as to efficacy and renal toxicity
de Oliveira, M. S., do Prado, G. V. B., Costa, S. F., Grinbaum, R. S., & Levin, A. S. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.07.018 · Cited by 99
Mojica, M. F., Rutter, J. D., Taracila, M. A., Abriata, L. A., Fouts, D. E., Papp‐Wallace, K. M., Walsh, T. J., LiPuma, J. J., Vila, A. J., & Bonomo, R. A. (2019) · mBio · doi:10.1128/mbio.00405-19 · Cited by 99
Self-citationShields, R. K., Iovleva, A., Kline, E. G., Kawai, A., McElheny, C. L., & Doi, Y. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa355 · Cited by 99
Gill, C. M., Aktaþ, E., Alfouzan, W. A., Bourassa, L. A., Brink, A. J., Burnham, C. D., Cantón, R., Carmeli, Y., Falcone, M., Kiffer, C. R. V., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04308-0 · Cited by 99
Self-citationChen, M., Nafziger, A. N., Drusano, G. L., Ma, L., & Bertino, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1222-1227.2006 · Cited by 98
Cheng, L., Nelson, B. C., Mehta, M., Seval, N., Park, S. E., Giddins, M. J., Shi, Q., Whittier, S., Gomez‐Simmonds, A., & Uhlemann, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00276-17 · Cited by 98
Makris, D. A., Petinaki, E., Tsolaki, V., Manoulakas, E., Mantzarlis, K. D., Apostolopoulou, O., Sfyras, D., & Zakynthinos, E. G. (2018) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_302_17 · Cited by 98
Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
Göttig, S., Frank, D., Mungo, E., Nolte, A., Hogardt, M., Besier, S. M., & Wichelhaus, T. A. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz330 · Cited by 98
Stewart, A. G., Paterson, D. L., Young, B. E., Lye, D. C., Davis, J. S., Schneider, K., Yılmaz, M., Dinleyici, R., Runnegar, N. J., Henderson, A., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab387 · Cited by 98
Kalın, G., Alp, E., Akin, A., Coskun, R., & Doğanay, M. (2013) · Infection · doi:10.1007/s15010-013-0495-y · Cited by 97
Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia
Siedner, M. J., Galar, A., Guzmán‐Suarez, B. B., Kubiak, D. W., Baghdady, N., Ferraro, M. J., Hooper, D. C., O’Brien, T. F., & Marty, F. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu182 · Cited by 97
Pfaller, M. A., Bassetti, M., Duncan, L. R., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx009 · Cited by 97
Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.
Al-Jasser, A. M. (2006) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-5-23 · Cited by 96
Pfaller, M. A., Huband, M. D., Mendes, R. E., Flamm, R. K., & Castanheira, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.02.021 · Cited by 96
Falagas, M. E., Kasiakou, S. K., Kofteridis, D. P., Roditakis, G., & Samonis, G. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0191-2 · Cited by 95
Aerosolized Antibiotics for Ventilator-associated Pneumonia
Rouby, J., Bouhemad, B., Monsel, A., Brisson, H., Arbelot, C., & Lü, Q. (2012) · Anesthesiology · doi:10.1097/aln.0b013e3182755d7a · Cited by 95
Morris, C. P., Bergman, Y., Tekle, T., Fissel, J. A., Tamma, P. D., & Simner, P. J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01649-20 · Cited by 95
Self-citationSatlin, M. J., Chen, L., Gomez‐Simmonds, A., Marino, J., Weston, G. D., Bhowmick, T., Seo, S. K., Sperber, S. J., Kim, A. C., Eilertson, B., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac354 · Cited by 94
Self-citationWood, G. C., Hanes, S. D., Boucher, B. A., Croce, M. A., & Fabian, T. C. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1811-2 · Cited by 93
Krizova, L., Poirel, L., Nordmann, P., & Nemec, A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt275 · Cited by 93
A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
Ritchie, D. J., & Garavaglia-Wilson, A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu613 · Cited by 92
Aph(3′)-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia
Okazaki, A., & Avison, M. B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00795-06 · Cited by 92
Harris, P. N. A., Wei, J. Y., Shen, A., Abdile, A. A., Paynter, S., Huxley, R., Pandeya, N., Doi, Y., Huh, K., O’Neal, C. S., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv346 · Cited by 92
Bostanghadiri, N., Ghalavand, Z., Fallah, F., Yadegar, A., Ardebili, A., Tarashi, S., Pournajaf, A., Mardaneh, J., Shams, S., & Hashemi, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01191 · Cited by 92
McLeod, S. M., Moussa, S. H., Hackel, M., & Miller, A. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02534-19 · Cited by 92
Ofer-Friedman, H., Shefler, C., Sharma, S., Tirosh, A., Tal-Jasper, R., Kandipalli, D., Sharma, S., Bathina, P., Kaplansky, T., Maskit, M., et al. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.101 · Cited by 91
Araoka, H., Baba, M., & Yoneyama, A. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0882-6 · Cited by 90
Robberts, F. J. L., Kohner, P. C., & Patel, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01687-08 · Cited by 89
Zelenitsky, S. A., Iacovides, H., Ariano, R. E., & Harding, G. K. M. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.09.002 · Cited by 89
Sader, H. S., Castanheira, M., Flamm, R. K., Mendes, R. E., Farrell, D. J., & Jones, R. N. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.02.022 · Cited by 89
Gaibani, P., Re, M. C., Campoli, C., Viale, P., & Ambretti, S. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.011 · Cited by 89
Castanheira, M., Mendes, R. E., & Jones, R. N. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu706 · Cited by 88
Kim, W., Moon, J.-Y., Huh, J. W., Choi, S., Lim, C., Koh, Y., Chong, Y. P., & Hong, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150642 · Cited by 88
Lenhard, J. R., Smith, N. M., Bulman, Z. P., Tao, X., Thamlikitkul, V., Shin, B. S., Nation, R. L., Li, J., Bulitta, J. B., & Tsuji, B. T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01268-16 · Cited by 88
MacVane, S. H., Pandey, R., Steed, L. L., Kreiswirth, B. N., & Chen, L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01183-17 · Cited by 88
Griffith, D. C., Sabet, M., Tarazi, Z., Lomovskaya, O., & Dudley, M. N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01659-18 · Cited by 88
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
Fröhlich, C., Sørum, V., Thomassen, A. M., Johnsen, P. J., Leiros, H. S., & Samuelsen, Ø. (2019) · mSphere · doi:10.1128/msphere.00024-19 · Cited by 88
Liang, C.-A., Lin, Y.-C., Lu, P., Chen, H.-C., Chang, H.-M., & Sheu, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.10.033 · Cited by 87
Sader, H. S., Mendes, R. E., Pfaller, M. A., Shortridge, D., Flamm, R. K., & Castanheira, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01856-17 · Cited by 87
Fraile-Ribot, P. A., Zamorano, L., Orellana, R., del Barrio-Tofiño, E., Sánchez-Diener, I., Cortés-Lara, S., López-Causapé, C., Cabot, G., Bou, G., Martı́nez-Martı́nez, L., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02165-19 · Cited by 87
Guerci, P., Bellut, H., Mokhtari, M., Gaudefroy, J., Mongardon, N., Charpentier, C., Louis, G., Tashk, P., Dubost, C., Ledochowski, S., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2649-5 · Cited by 87
Kawai, A., McElheny, C. L., Iovleva, A., Kline, E. G., Sluis‐Cremer, N., Shields, R. K., & Doi, Y. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00198-20 · Cited by 87
Falcone, M., Giordano, C., Leonildi, A., Galfo, V., Lepore, A., Suardi, L., Riccardi, N., Barnini, S., & Tiseo, G. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad725 · Cited by 87
Shortridge, D., Castanheira, M., Pfaller, M. A., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00465-17 · Cited by 86
Karlowsky, J. A., Lob, S. H., Kazmierczak, K. M., Hawser, S., Magnet, S., Young, K., Motyl, M. R., & Sahm, D. F. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky107 · Cited by 86
Chan, J. D., Graves, J. A., & Dellit, T. H. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610377975 · Cited by 85
Wilson, W. R., Kline, E. G., Jones, C. E., Morder, K. M., Mettus, R. T., Doi, Y., Nguyen, M. H., Clancy, C. J., & Shields, R. K. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02048-18 · Cited by 85
Lan, P., Lu, Y., Chen, Z., Wu, X., Hua, X., Jiang, Y., Zhou, J., & Yu, Y. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00084-22 · Cited by 85
Eckmann, C., Montravers, P., Bassetti, M., Bodmann, K. ‐., Heizmann, W. R., García, M. S., Guirao, X., Capparella, M. R., Simoneau, D., & Dupont, H. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt142 · Cited by 84
Wei, C., Ni, W., Cai, X., Zhao, J., & Cui, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152132 · Cited by 84
Butler, D. A., Biagi, M. J., Tan, X., Qasmieh, S., Bulman, Z. P., & Wenzler, E. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0706-5 · Cited by 84
Pascale, R., Pasquini, Z. A. I., Bartoletti, M., Caiazzo, L., Fornaro, G., Bussini, L., Volpato, F., Marchionni, E., Rinaldi, M., Trapani, F., et al. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab174 · Cited by 84
Sader, H. S., Mendes, R. E., Carvalhaes, C. G., Kimbrough, J. H., & Castanheira, M. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad046 · Cited by 84
Russo, A., Bruni, A., Gullì, S. P., Borrazzo, C., Quirino, A., Lionello, R., Serapide, F., Garofalo, E., Serraino, R., Romeo, F., et al. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106825 · Cited by 84
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
Lee, N., Lee, C., Li, C., Li, M.-C., Chen, P., Chang, C., & Ko, W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01477-15 · Cited by 83
Punjabi, C. D., Tien, V., Meng, L., Deresinski, S. C., & Holubar, M. K. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz364 · Cited by 83
Lodise, T. P., Smith, N. M., O’Donnell, J. N., Eakin, A. E., Holden, P. N., Boissonneault, K. R., Zhou, J., Tao, X., Bulitta, J. B., Fowler, V. G., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa197 · Cited by 83
Self-citationSader, H. S., Castanheira, M., Mendes, R. E., & Flamm, R. K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky279 · Cited by 82
Alraddadi, B. M., Saeedi, M. F., Qutub, M., Alshukairi, A. N., Hassanien, A., & Wali, G. Y. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4409-1 · Cited by 82
Reddy, T., Chopra, T., Marchaim, D., Pogue, J. M., Alangaden, G. J., Salimnia, H., Boikov, D. A., Navon‐Venezia, S., Akins, R. A., Selman, P., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01665-09 · Cited by 81
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
Fukuchi, T., Iwata, K., Kobayashi, S., Nakamura, T., & Ohji, G. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1770-1 · Cited by 81
Mojica, M. F., Papp‐Wallace, K. M., Taracila, M. A., Barnes, M. D., Rutter, J. D., Jacobs, M. R., LiPuma, J. J., Walsh, T. J., Vila, A. J., & Bonomo, R. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00777-17 · Cited by 81
Self-citationKazakova, S. V., Baggs, J. M., McDonald, L. C., Yi, S. H., Hatfield, K. M., Guh, A. Y., Reddy, S. C., & Jernigan, J. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz169 · Cited by 81
Kawaguchi, N., Katsube, T., ECHOLS, R. M., & Wajima, T. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01437-20 · Cited by 81
Harada, Y., Morinaga, Y., Kaku, N., Nakamura, S., Uno, N., Hasegawa, H., Izumikawa, K., KOHNO, S., & Yanagihara, K. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12677 · Cited by 80
Burgess, D. S., & Hall, R. G. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2003.11.007 · Cited by 80
Doi, A., Shimada, T., Harada, S., Iwata, K., & Kamiya, T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.09.010 · Cited by 80
Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis
Brink, A. J., Richards, G., Schillack, V., Kiem, S., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.005 · Cited by 80
ALLEN, J. C. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-482 · Cited by 80
Mojica, M. F., Ouellette, C. P., Leber, A. L., Becknell, B., Ardura, M. I., Pérez, F., Shimamura, M., Bonomo, R. A., Aitken, S. L., & Shelburne, S. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00264-16 · Cited by 80
Self-citationSimner, P. J., Beisken, S., Bergman, Y., Posch, A. E., Cosgrove, S. E., & Tamma, P. D. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab311 · Cited by 80
Self-citationHakeam, H. A., Al-Sahli, H., Albabtain, L., Alassaf, S., Duhailib, Z. A., & Althawadi, S. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.079 · Cited by 80
Findlay, J., Poirel, L., Bouvier, M., & Nordmann, P. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.05.011 · Cited by 79
Senchyna, F., Gaur, R. L., Sandlund, J., Truong, C., Tremintin, G., Kültz, D., Gómez, C. A., Tamburini, F. B., Andermann, T. M., Bhatt, A. S., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.004 · Cited by 78
Streling, A. P., Al‐Obaidi, M. M., Lainhart, W., Zangeneh, T. T., Khan, A., Dinh, A. Q., Hanson, B., Arias, C. A., & Miller, W. R. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1909 · Cited by 78
Diverse potential of beta-lactamase inhibitors to induce class I enzymes
Weber, D. A., & Sanders, C. C. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.156 · Cited by 77
Hand, E., Davis, H., Kim, T., & Duhon, B. M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv456 · Cited by 77
Stone, G. G., Newell, P., Gasink, L. B., Broadhurst, H., Wardman, A., Yates, K., Chen, Z., Song, J., & Chow, J. W. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky204 · Cited by 77
Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii
Bowers, D. R., Cao, H., Zhou, J. M., Ledesma, K. R., Sun, D., Lomovskaya, O., & Tam, V. H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04110-14 · Cited by 76
Sharara, S. L., Amoah, J., Pana, Z. D., Simner, P. J., Cosgrove, S. E., & Tamma, P. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1205 · Cited by 76
Self-citationSader, H. S., Carvalhaes, C. G., Arends, S. J. R., Castanheira, M., & Mendes, R. E. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa504 · Cited by 76
Torrens, G., van der Schalk, T. E., Cortés-Lara, S., Timbermont, L., del Barrio-Tofiño, E., Xavier, B. B., Zamorano, L., Lammens, C., Ali, O., Ruzin, A. V., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac122 · Cited by 76
Doshi, N., Cook, C. H., Mount, K. L., Stawicki, S. P., Frazee, E. N., Personett, H. A., Schramm, G. E., Arnold, H. M., & Murphy, C. V. (2013) · BMC Anesthesiology · doi:10.1186/1471-2253-13-45 · Cited by 75
Cañestro, M. D., Periañez, L., Mulet, X., Martín-Pena, M. L., Fraile-Ribot, P. A., Ayestarán, I., Colomar, A., Núñez, B., Macia, M. D., Novo, A., et al. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3361-0 · Cited by 75
Castanheira, M., Deshpande, L. M., Woosley, L. N., Serio, A. W., Krause, K. M., & Flamm, R. K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky344 · Cited by 75
Castanheira, M., Doyle, T. B., Collingsworth, T. D., Sader, H. S., & Mendes, R. E. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab306 · Cited by 75
McElheny, C. L., Fowler, E. L., Iovleva, A., Shields, R. K., & Doi, Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01779-21 · Cited by 75
Cho, S., Lee, D., Choi, S., Park, C., Chun, H., Park, Y.-J., Choi, J.-K., Lee, H.-J., Park, S. H., Choi, J., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0801-7 · Cited by 74
Demırdal, T., Sarı, Ü. S., & Nemli, S. A. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0123-7 · Cited by 74
Karlowsky, J. A., Lob, S. H., Raddatz, J. K., DePestel, D. D., Young, K., Motyl, M. R., & Sahm, D. F. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa381 · Cited by 74
Simner, P. J., Bergman, Y., Conzemius, R., Jacobs, E. B., Tekle, T., Beisken, S., & Tamma, P. D. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad276 · Cited by 74
Self-citationZhou, C., Jin, L., Wang, Q., Wang, X., Chen, F., Gao, Y., Zhao, C., Chen, H., Cao, B., & Wang, H. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s294282 · Cited by 73
YILMAZ, G. R., Güven, T., Güner, R., Tufan, Z. K., İzdeş, Ş., Tasyaran, M. A., & Açıkgöz, Z. C. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6195 · Cited by 72
Park, H. J., Cho, J. H., Kim, H. J., Han, S. H., Jeong, S. H., & Byun, M. K. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.11.016 · Cited by 72
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam Resistance
Tamma, P. D., Beisken, S., Bergman, Y., Posch, A. E., Avdic, E., Sharara, S. L., Cosgrove, S. E., & Simner, P. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1306 · Cited by 72
Self-citationMeschiari, M., Volpi, S., Faltoni, M., Dolci, G., Orlando, G., Franceschini, E., Menozzi, M., Sarti, M., Fabro, G. D., Fumarola, B., et al. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab188 · Cited by 72
Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia
Jeon, Y. D., Jeong, W., Kim, M. H., Jung, I. Y., Ahn, M. Y., Ann, H. W., Ahn, J. Y., Han, S. H., Choi, J. Y., Song, Y. G., et al. (2016) · Medicine · doi:10.1097/md.0000000000004375 · Cited by 71
Pfaller, M. A., Huband, M. D., Shortridge, D., & Flamm, R. K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02327-17 · Cited by 71
Periasamy, H., Joshi, P., Palwe, S. R., Shrivastava, R., Bhagwat, S., & Patel, M. V. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa021 · Cited by 71
Luna, B. M., Trebosc, V., Lee, B., Bakowski, M. A., Ulhaq, A., Yan, J., Lu, P., Cheng, J., Nielsen, T. B., Lim, J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0737-6 · Cited by 71
Cefpodoxime vs Ciprofloxacin for Short-Course Treatment of Acute Uncomplicated Cystitis
Hooton, T. M., Roberts, P. L., & Stapleton, A. E. (2012) · JAMA · doi:10.1001/jama.2012.80 · Cited by 70
Sánchez, M. B., & Martínez, J. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-15 · Cited by 70
Rodríguez-Hernández, M. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.479 · Cited by 70
Wang, R., Cosgrove, S. E., Tschudin‐Sutter, S., Han, J., Turnbull, A. E., Hsu, A. J., Avdic, E., Carroll, K. C., & Tamma, P. D. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw132 · Cited by 70
Self-citationMcLeod, S. M., Shapiro, A. B., Moussa, S. H., Johnstone, M. R., McLaughlin, R. E., DeJonge, B. L. M., & Miller, A. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01576-17 · Cited by 69
Aitken, S. L., Tarrand, J. J., Deshpande, L. M., Tverdek, F. P., Jones, A. L., Shelburne, S. A., Prince, R. A., Bhatti, M. M., Rolston, K. V. I., Jones, R. N., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw398 · Cited by 68
Risk factors for death from Stenotrophomonas maltophilia bacteremia
Osawa, K., Shigemura, K., Kitagawa, K., Tokimatsu, I., & Fujisawa, M. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.03.011 · Cited by 68
Karlowsky, J. A., Kazmierczak, K. M., Bouchillon, S. K., DeJonge, B. L. M., Stone, G. G., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02569-17 · Cited by 68
Petrella, S., Clermont, D., Casin, I., Jarlier, V., & Sougakoff, W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.8.2287-2298.2001 · Cited by 66
Szabó, D., Bonomo, R. A., Silveira, F. P., Pasculle, A. W., Baxter, C. M., Linden, P. K., Hujer, A. M., Hujer, K. M., Deeley, K. B., & Paterson, D. L. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5058-5064.2005 · Cited by 66
Self-citationRubio, A. M., Kline, E. G., Jones, C. E., Chen, L., Kreiswirth, B. N., Nguyen, M. H., Clancy, C. J., Cooper, V. S., Haidar, G., Tyne, D. V., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00084-21 · Cited by 66
Alsenani, T. A., Viviani, S. L., Kumar, V., Taracila, M. A., Bethel, C. R., Barnes, M. D., Papp‐Wallace, K. M., Shields, R. K., Nguyen, M. H., Clancy, C. J., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02414-21 · Cited by 66
Self-citationEvolution of β-lactamase-mediated cefiderocol resistance
Fröhlich, C., Sørum, V., Tokuriki, N., Johnsen, P. J., & Samuelsen, Ø. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac221 · Cited by 66
Hilty, M., Sendi, P., Seiffert, S. N., Droz, S., Perreten, V., Hujer, A. M., Bonomo, R. A., Mühlemann, K., & Endimiani, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.022 · Cited by 65
Self-citationSader, H. S., Castanheira, M., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02083-16 · Cited by 65
Pharmacokinetics and Pharmacodynamics of β‐Lactamase Inhibitors
Crass, R. L., & Pai, M. P. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2210 · Cited by 65
Castanheira, M., Doyle, T. B., Kantro, V., Mendes, R. E., & Shortridge, D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01951-19 · Cited by 65
Biagi, M. J., Tan, X., Wu, T.-S., Jurkovic, M., Vialichka, A., Meyer, K., Mendes, R. E., & Wenzler, E. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01603-19 · Cited by 65
Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii
Tseng, Y., Wang, J., Wu, F. L., Chen, Y., Chie, W., & Chang, S. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.04.024 · Cited by 64
Goff, D. A., Bauer, K. A. A., & Mangino, J. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu593 · Cited by 64
Biagi, M. J., Vialichka, A., Jurkovic, M., Wu, T.-S., Shajee, A., Lee, M., Patel, S., Mendes, R. E., & Wenzler, E. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00559-20 · Cited by 64
Shropshire, W. C., Aitken, S. L., Pifer, R., Kim, J., Bhatti, M. M., Li, X., Kalia, A., Galloway-Peña, J., Sahasrabhojane, P. V., Arias, C. A., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa447 · Cited by 64
Yokoyama, Y., Matsumoto, K., Ikawa, K., Watanabe, E., Shigemi, A., Umezaki, Y., Nakamura, K., Ueno, K., Morikawa, N., & Takeda, Y. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.012 · Cited by 63
Naesens, R., Vlieghe, E., Verbrugghe, W., Jorens, P. G., & Ieven, M. M. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-317 · Cited by 63
Tato, M., García-Castillo, M., Bofarull, A. M., & Cantón, R. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.004 · Cited by 63
Pfaller, M. A., Huband, M. D., Shortridge, D., & Flamm, R. K. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02488-19 · Cited by 63
Defining Baseline Mechanisms of Cefiderocol Resistance in the Enterobacterales
Simner, P. J., Beisken, S., Bergman, Y., Ante, M., Posch, A. E., & Tamma, P. D. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2021.0095 · Cited by 63
Self-citationEstebanez, A., Pascual, R., Gil, V., Ortiz, F., Santibáñez, M., & Barba, C. P. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0805-6 · Cited by 62
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
Falagas, M. E., Karageorgopoulos, D. E., & Dimοpoulos, G. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048356 · Cited by 62
Fung-Tomc, J. C., Gradelski, E., Huczko, E., Dougherty, T. J., KESSLER, R. E., & BONNER, D. P. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1289 · Cited by 62
Sader, H. S., Flamm, R. K., Carvalhaes, C. G., & Castanheira, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01587-18 · Cited by 62
Cai, B., Tillotson, G., Benjumea, D., Callahan, P. M., & ECHOLS, R. M. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa141 · Cited by 62
Cited by
Multidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Rahimbakhsh, A., Seyfahmadi, M., Souldozi, A., Hakimelahi, R., Alikhani, M. Y., & Kafilzadeh, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-23260-z · Cited by 1
Zhang, Y., Liao, G., Song, J., Liao, Y., & Zhang, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1924203
Metadata
- Authors
- Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-08-07
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4401413536
- Cited by
- 1,191
- References
- 717
- FWCI
- 125.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.